BIOPX Performance — Baron Opportunity Fund, Retail Shares

Data updated: 2026-08-28

BIOPX returned +15.65% year to date and +27.41% over one year to Jun 2026. Annualised returns are +28.24% over 3 years and +10.71% over 5 years. The fund beat its US Large Growth category average: $100 invested three years ago grew to $211, against $175 for the category, and to $127 over one year, against $117. Volatility over the past three years was 19.48% a year. In the 12 months to Jun 2026 the fund took in a net $84.9M, and assets reached $2.12B.

BIOPX Growth of $100

What $100 invested in Baron Opportunity Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Large Growth category average over the same months.

PeriodBIOPXCategory average
1 year (Jul 2025 – Jun 2026)$127$117
3 years (Jul 2023 – Jun 2026)$211$175
5 years (Jul 2021 – Jun 2026)$166$166
Since data start (Jul 2019 – Jun 2026)$380$271

BIOPX Trailing Returns

Total returns to Jun 2026, from SEC N-PORT.

PeriodTotal return
YTD+15.65%
1 year+27.41%
3 years (annualised)+28.24%
5 years (annualised)+10.71%

BIOPX Annual Returns

Calendar-year total returns of Baron Opportunity Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.

YearTotal return
2026 (Jan–Jun)+15.65%
2025+19.42%
2024+39.87%
2023+49.57%
2022−42.97%
2021+12.01%
2020+88.75%
2019 (Jul–Dec)+8.95%

BIOPX Monthly Returns

Monthly total returns as reported on SEC Form N-PORT.

YearJanFebMarAprMayJunJulAugSepOctNovDec
2026−3.4%−1.7%−4.2%+10.6%+8.7%+5.6%——————
2025+3.9%−5.1%−10.8%+2.8%+12.1%+7.0%+3.2%−1.3%+3.4%+4.0%−2.6%+3.2%
2024+2.6%+10.2%+1.9%−6.8%+3.5%+8.2%−1.1%+0.8%+4.3%+1.1%+8.9%+1.6%
2023+10.4%0.0%+6.8%−1.7%+11.5%+6.1%+3.7%−3.6%−5.1%−3.8%+13.4%+5.4%
2022−15.4%−3.1%+2.3%−16.6%−5.8%−7.1%+11.2%−2.2%−10.3%+3.1%+1.4%−8.7%
2021+2.2%+4.5%−5.5%+6.0%−3.5%+7.5%−1.3%+2.8%−3.5%+7.4%−2.1%−2.0%
2020+6.2%−1.7%−10.7%+14.8%+10.5%+10.2%+7.0%+11.1%−0.9%−0.4%+13.0%+9.3%
2019——————+1.1%−2.1%−3.5%+3.8%+8.4%+1.4%

BIOPX Risk

Risk measures from monthly returns over Jul 2023 – Jun 2026.

  • 3-year volatility (annualised): 19.48%
  • 3-year Sharpe ratio: 1.22 (vs 4.5% risk-free rate)
  • Best month: +13.39% (Nov 2023)
  • Worst month: −10.80% (Mar 2025)

BIOPX Fund Flows

Monthly money in and out of Baron Opportunity Fund, from SEC Form N-PORT.

  • 12-month net flow: $84.9M
  • 12-month gross sales (incl. reinvestments): $717.8M
  • Sales ÷ redemptions: 1.13×
MonthSalesRedemptionsNet flow
Jun 2026$75.9M$43.9M$31.9M
May 2026$41.9M$22.6M$19.3M
Apr 2026$61.8M$54.3M$7.5M
Mar 2026$56.6M$62.1M−$5.5M
Feb 2026$147.0M$158.0M−$11.1M
Jan 2026$38.8M$42.4M−$3.6M
Dec 2025$124.0M$63.7M$60.3M
Nov 2025$13.9M$29.9M−$16.0M
Oct 2025$40.4M$55.1M−$14.7M
Sep 2025$56.3M$44.4M$11.9M
Aug 2025$38.6M$33.3M$5.3M
Jul 2025$22.8M$23.3M−$469K

BIOPX Assets Under Management

Net assets of Baron Opportunity Fund by report date, from SEC N-PORT filings.

Report dateNet assets
2026-06-30$2.12B
2026-03-31$1.62B
2025-12-31$1.80B
2025-09-30$1.76B
2025-06-30$1.65B
2025-03-31$1.35B
2024-12-31$1.51B
2024-09-30$1.36B
2024-06-30$1.33B
2024-03-31$1.30B
2023-12-31$1.13B
2023-09-30$996.02M

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.